SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage, investment advisory, and banking and trust services to individual investors, retirement plan and business services, as well as other corporate brokerage services, to businesses and employees. The Advisor Services segment provides custodial, trading, banking and trust, and support services to independent registered investment advisors, independent retirement advisors, and recordkeepers. The company was founded by Charles Robert Schwab in 1986 and is headquartered in Westlake, TX.

Charles Schwab Corp.

Charles Schwab is trending as a new AI tool for tax planning from Altruist Corp. sparks concerns about industry disruption, leading to a broader sell-off across financial stocks. Community sentiment is divided, with some calling the market's reaction overdone while others are vocal about ongoing frustrations with Schwab's platform and trading restrictions.

Evommune, Inc. is a clinical-stage biotechnology company. It engages in the development of medicines for inflammatory diseases. The company was founded by Luis C. Pena, Eugene Andrew Bauer, and Hans Hofland in 2020 and is headquartered in Palo Alto, CA.

Evommune Inc.

Evommune Inc

Evommune (EVMN) is experiencing significant market interest following positive top-line data from its Phase 2a trial for EVO301, an eczema treatment that met its primary endpoint. The announcement has sparked a heated debate among traders, with many anticipating a short squeeze while others express caution regarding its valuation.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. TeraWulf will generate domestically produced bitcoin powered by nuclear, hydro and solar energy. The company was founded by Paul Prager and Nazar Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is trending after Morgan Stanley initiated coverage with an "Overweight" rating and a $37 price target, emphasizing the company's strong position in transitioning from Bitcoin mining to AI data centers. The community is buzzing with speculation about imminent hyperscaler deals and the potential for a significant short squeeze, anticipating further price breakouts.

Spotify Technology SA engages in the provision of digital music services. It operates through the Premium and Ad-Supported segments. The Premium segment provides subscribers with online and offline streaming access of music and podcasts on computers, tablets, and mobile devices. The Ad-Supported segment offers users with limited on-demand online access of music and unlimited online access of podcasts on computers, tablets, and mobile and smart devices. The company was founded by Daniel Ek and Martin Lorentzon on December 27, 2006 and is headquartered in Luxembourg.

Spotify Technology S.A.

Spotify (SPOT) is surging after reporting a blockbuster Q4, driven by record user growth, increased premium subscribers, and improved profitability, fueling widespread bullish sentiment and discussions of a potential short squeeze.

Senseonics Holdings, Inc. is a medical technology company, which engages in the development and manufacture of glucose monitoring products. Its primary product is the brand Eversense CGM (continuous glucose monitoring) including sensors, smart transmitters, and mobile applications. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.

Senseonics Holdings Inc

Senseonics is trending following its CE Mark approval for the Eversense 365 CGM system in Europe and the launch of its first commercial integration with an automated insulin delivery (AID) system, driving community excitement about market adoption and the potential for a significant short squeeze.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is a hot topic following multiple analyst price target increases and positive remarks from PepsiCo's earnings about robust Celsius and Alani Nu distribution. While recent market dips and chatter around new competition create short-term volatility, the community sees current levels as a strong buying opportunity ahead of anticipated solid earnings.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is seeing a significant downturn in its stock as the Centers for Medicare & Medicaid Services proposed near-flat Medicare Advantage payment rates for 2027, below market expectations. This has led to substantial selling pressure and the stock trading at multi-year lows, with some in the community viewing the dip as an attractive buying opportunity while others express concern over the company's high reliance on MA.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending after a patent infringement lawsuit from Novo Nordisk and FDA scrutiny led the company to halt its oral semaglutide pill offering. The community is sharply divided, with many fearing bankruptcy and further declines due to regulatory and legal challenges, while others view it as an oversold "short squeeze" candidate given its strong core business.

Jumia Technologies AG engages in the provision of logistic services. It operates a pan-African e-commerce platform. It operates through the following geographical segments: West Africa, North Africa, East and South Africa, Europe, United Arab Emirates, and Others. The company was founded by Jeremy Hodara, Sacha Poignonnec, Peter Allerstorfer, Manuel Koser, Tunde Kehinde, and Raphael Afaedor in 2012 and is headquartered in Berlin, Germany.

Jumia Technologies Ag - ADR

Jumia is actively discussed following its recent earnings report, which showcased significant revenue and GMV growth, substantially reduced losses, and a reaffirmed trajectory towards profitability. While some investors are buying the dip and reinforcing their long-term conviction in Jumia as Africa's leading e-commerce player, others are reacting to short-term volatility in what some perceive as a 'sell the news' event.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Next, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Next segment is involved in the expenses and investments for emerging business initiatives aimed at creating value for Ford in vehicle-adjacent market segments. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is trending as investors anticipate its upcoming earnings report, with community discussions focused on the company's strategic pivot towards hybrids and away from all-electric vehicles, alongside options activity and recent recalls. This reevaluation occurs amid broader auto sector shifts in EV demand and talks of potential battery partnerships with Chinese firms.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced two key additions...

Deborah Kaster Purchases 15,000 Shares of Adagio Medical (NASDAQ:ADGM) Stock

Adagio Medical Holdings, Inc. (NASDAQ:ADGM - Get Free Report) CFO Deborah Kaster purchased 15,000 shares of the company's stock in a transaction on Tuesday, December 16th. The stock was purchased at...

Adagio Medical Appoints Industry Veteran Sean Salmon to Board of Directors

Adagio Medical Holdings, Inc (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that Sean Salmon...

Adagio Medical Reports Third Quarter 2025 Results

Adagio Medical Holdings, Inc (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced financial results...

Adagio Medical to Present at the Piper Sandler 37th Annual Healthcare Conference

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that management...

Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced that it has...

Adagio Medical Unveils Preliminary Acute Results from FULCRUM-VT U.S. Pivotal Study in Late Breaking Session at VT Symposium

Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (Adagio or the Company), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced preliminary acute...

Shares of Adagio Medical Holdings, Inc. (ADGM) experienced a significant surge in retail investor interest last week as they gained over 122%, driven by regulatory approval for a medical device.On Thursday, Adagio said its vCLAS Cryoablation System had been granted Breakthrough Device designation by the U.S. Food and Drug Administration (FDA) for the treatment of drug-refractory, recurrent, sustained monomorphic ventricular tachycardia (VT) in patients with structural heart disease.&nbsp;&nbsp;&nbsp;CEO Todd Usen said the regulatory nod marked a significant milestone for Adagio as it validated its proprietary system as a "potentially unique solution for the large, underserved population of patients suffering from ventricular tachycardia.""We are thrilled to be the only technology to be granted Breakthrough Device designation for endocardial treatment of both ischemic and nonischemic structural heart disease patients with sustained monomorphic VT," he added.Adagio said the FDA's decision was partly based on clinical data from Adagio's European CRYOCURE-VT study.The news resulted in Adagio's retail following on Stocktwits jumping by over 64% last week, with message volume flipping to 'extremely high' levels and sentiment surging to 'extremely bullish.'<figure class="image"><img style="aspect-ratio:1318/316;" src="https://news.stocktwits-cdn.com/ADGM_sentiment_and_message_volume_weekly_as_of_April_20_png_377c1aa693.webp" alt="ADGM sentiment and message volume weekly as of April 20.png" width="1318" height="316"><figcaption>ADGM sentiment and message volume weekly as of April 20. | source: Stocktwits</figcaption></figure>One user called the stock surge the "best setup for a major squeeze," although Koyfin data showed Adagio has a relatively low short interest of just 0.5%.The free float, however, stands at just over 15 million.<stembedurl>https://stocktwits.com/DaSqueeza/message/612042599</stembedurl>Another believed Adagio would nearly triple on Monday.<stembedurl>https://stocktwits.com/umiy/message/612011651</stembedurl><a href="https://stocktwits.com/symbol/ADGM">Adagio's stock</a> has gained more than 45% this year but is down over 84% in the past 12 months.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

Why Nano-Cap Adagio Medical Saw The Highest Weekly Spurt In Retail Following Among Healthcare Stocks

The company said the FDA’s nod validates its proprietary system as a "potentially unique solution for the large, underserved population of patients suffering from ventricular tachycardia."

Adagio Medical Leads Weekly Retail Follower Surge Among Healthcare Stocks On Breakthrough Device Approval

Equity

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in Laguna Hills, CA.

ADGM
Adagio Medical Holdings Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest ADGM News

ADGMAdagio Medical Holdings Inc.